Monthly Archives: August 2013

EACPT Lifetime Achievement Awards presented in Geneva to Professor Sir Michael Rawlins and Professor Carlo Patrono

Today in Geneva, EACPT Lifetime Achievement Awards were presented to Professor Carlo Patrono and to Professor Sir Michael Rawlins for their outstanding contributions to the national and international benefits of clinical pharmacology for medicine, health care and patient safety.

Sir Michael Rawlins and Carlo Patrono

These Awards, including the EACPT silver medal, were presented at an Awards Ceremony the 11th EACPT Congress in Geneva, 28th – 31st August 2013 by EACPT co-founder Professor Folke Sjöqvist, and by Dr Marie Besson, co-leader of the 2011 EACPT Congress.…

Masterclass by EACPT official journal editor Richard Shader on how to publish in scientific journals

At 8am a well-attended session at the CICG in Geneva on how to publish scientific work – over 60 delegates here for a Masterclass by EACPT official journal editor Richard Shader, day 2 of the 11th EACPT Congress 28-31 August. Some deceptively simple messages including– work back from key results– decide title and write abstract last – write clearly– avoid excessive use of adverbs  – use short sentences– consider use of translation support if English is not your first language [This should be translation of your own text, NOT ghost writing]– explain why you undertook the work– describe how you advanced knowledge in the field.– note further work that would take the field forward.…

11th EACPT Congress underway in Geneva 28-31 August 2013

Around 600 young and senior pharmacologists from 5 continents are now in Geneva for the 11th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). 

More about the 11th EACPT Congress in Geneva.
Viewand download Congress Programme
View Congress Abstracts ONLINE at the Clinical Therapeutics website
The Geneva Congress brings together a wide range of international delegates, including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs.…

Skip to toolbar